Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

L3HYPDH Activators

L3HYPDH (trans-L-3-hydroxyproline dehydratase) can be functionally activated through various biochemical mechanisms, primarily involving phosphorylation events that alter its activity. Specific activators exert their influence through modulation of intracellular signaling pathways, leading to enhanced phosphorylation and resultant activity of L3HYPDH. For instance, activation of adenylyl cyclase leads to an increase in cyclic AMP (cAMP) levels, which is known to activate protein kinase A (PKA). Once activated, PKA can phosphorylate target proteins, including L3HYPDH, thereby enhancing its enzymatic function. Similarly, activation of protein kinase C (PKC) through certain activators results in phosphorylation events that may include L3HYPDH as a target. PKC activation is commonly triggered by diacylglycerol analogs and can lead to phosphorylation of various proteins, potentially influencing L3HYPDH activity as well. Furthermore, elevations in intracellular calcium levels can activate calcium-dependent protein kinases, which are capable of phosphorylating a range of substrates, potentially including L3HYPDH, thereby modulating its activity.

Apart from phosphorylation, L3HYPDH activity can be indirectly influenced by alterations in other signaling pathways that affect its expression levels or the activation of related proteins. For example, the PI3K/AKT signaling pathway, which can be modulated by insulin, plays a critical role in a multitude of cellular processes, including protein phosphorylation. Alterations in this pathway could lead to enhanced L3HYPDH activation through potential downstream phosphorylation events. Additionally, the JNK/SAPK pathway, which responds to various stress stimuli, can activate transcription factors that may augment L3HYPDH expression and activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C (PKC) which could phosphorylate L3HYPDH or associated proteins, resulting in enhanced L3HYPDH activity.

Ionomycin, free acid

56092-81-0sc-263405
sc-263405A
1 mg
5 mg
$96.00
$264.00
2
(2)

Increases intracellular calcium concentration, which may activate calcium-dependent protein kinases that phosphorylate L3HYPDH, thereby increasing its activity.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic receptor agonist which increases intracellular levels of cAMP, potentially leading to activation of PKA and subsequent phosphorylation and activation of L3HYPDH.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$156.00
$1248.00
$12508.00
82
(1)

Activates the PI3K/AKT signaling pathway which can lead to the phosphorylation and activation of proteins, including L3HYPDH.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Stimulates adenylyl cyclase through G-protein coupled receptors, increasing cAMP levels and potentially leading to PKA-mediated L3HYPDH activation.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-specific inhibitor of phosphodiesterases, leading to increased cAMP levels which could enhance PKA activity and subsequently L3HYPDH activity.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

A cAMP analog that activates PKA, which could then phosphorylate and activate L3HYPDH.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

A cAMP analog that permeates cell membranes and activates PKA, which can lead to increased L3HYPDH activity through phosphorylation.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Activator of the JNK/SAPK signaling pathway, which could lead to the activation of transcription factors that elevate L3HYPDH expression and activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibitor of PI3K, leading to alterations in downstream signaling pathways which may indirectly upregulate and activate L3HYPDH through compensatory mechanisms.